{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:17:06Z","timestamp":1767140226313,"version":"build-2238731810"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Grant No. 81802975"],"award-info":[{"award-number":["Grant No. 81802975"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["Grant No. LY18H180010"],"award-info":[{"award-number":["Grant No. LY18H180010"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017532","name":"Medical Technology and Education of Zhejiang Province of China","doi-asserted-by":"publisher","award":["Gran No. 2019KY361"],"award-info":[{"award-number":["Gran No. 2019KY361"]}],"id":[{"id":"10.13039\/501100017532","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2020KY101"],"award-info":[{"award-number":["2020KY101"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00705-023-05931-2","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T04:04:10Z","timestamp":1701230650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Characteristics and mechanisms of latency-reversing agents in the activation of the human immunodeficiency virus 1 reservoir"],"prefix":"10.1007","volume":"168","author":[{"given":"Zhujiao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yashuang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1139-4802","authenticated-orcid":false,"given":"Geng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"issue":"1","key":"5931_CR1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tips.2021.10.004","volume":"43","author":"L Men\u00e9ndez-Arias","year":"2022","unstructured":"Men\u00e9ndez-Arias L, Delgado R (2022) Update and latest advances in antiretroviral therapy. Trends Pharmacol Sci 43(1):16\u201329","journal-title":"Trends Pharmacol Sci"},{"key":"5931_CR2","doi-asserted-by":"crossref","first-page":"945956","DOI":"10.3389\/fcimb.2022.945956","volume":"12","author":"J Chen","year":"2022","unstructured":"Chen J, Zhou T, Zhang Y, Luo S, Chen H, Chen D, Li C, Li W (2022) The reservoir of latent HIV. Front Cell Infect Microbiol 12:945956","journal-title":"Front Cell Infect Microbiol"},{"issue":"4","key":"5931_CR3","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.3390\/v6041837","volume":"6","author":"A Kumar","year":"2014","unstructured":"Kumar A, Abbas W, Herbein G (2014) HIV-1 latency in monocytes\/macrophages. Viruses 6(4):1837\u20131860","journal-title":"Viruses"},{"key":"5931_CR4","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.3389\/fmicb.2019.02828","volume":"10","author":"Z Kruize","year":"2019","unstructured":"Kruize Z, Kootstra NA (2019) The Role of Macrophages in HIV-1 Persistence and Pathogenesis. Front Microbiol 10:2828","journal-title":"Front Microbiol"},{"key":"5931_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ircmb.2019.07.004","volume":"348","author":"S Balan","year":"2019","unstructured":"Balan S, Saxena M, Bhardwaj N (2019) Dendritic cell subsets and locations. Int Rev Cell Mol Biol 348:1\u201368","journal-title":"Int Rev Cell Mol Biol"},{"key":"5931_CR6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1146\/annurev-immunol-101819-025146","volume":"39","author":"X Yin","year":"2021","unstructured":"Yin X, Chen S, Eisenbarth SC (2021) Dendritic Cell Regulation of T Helper Cells. Annu Rev Immunol 39:759\u2013790","journal-title":"Annu Rev Immunol"},{"key":"5931_CR7","doi-asserted-by":"crossref","unstructured":"Yu HJ, Reuter MA, McDonald D (2008) HIV traffics through a specialized, surface-accessible intracellular compartment during trans-infection of T cells by mature dendritic cells. PLoS Pathog 4 (8), e1000134","DOI":"10.1371\/journal.ppat.1000134"},{"issue":"3","key":"5931_CR8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.chom.2011.02.005","volume":"9","author":"CC Carter","year":"2011","unstructured":"Carter CC, McNamara LA, Onafuwa-Nuga A, Shackleton M, Riddell Jt, Bixby D, Savona MR, Morrison SJ, Collins KL (2011) HIV-1 utilizes the CXCR4 chemokine receptor to infect multipotent hematopoietic stem and progenitor cells. Cell Host Microbe 9(3):223\u2013234","journal-title":"Cell Host Microbe"},{"issue":"4","key":"5931_CR9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nm.2109","volume":"16","author":"CC Carter","year":"2010","unstructured":"Carter CC, Onafuwa-Nuga A, McNamara LA, Riddell Jt, Bixby D, Savona MR, Collins KL (2010) HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat Med 16(4):446\u2013451","journal-title":"Nat Med"},{"key":"5931_CR10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coph.2019.03.003","volume":"48","author":"A Bandera","year":"2019","unstructured":"Bandera A, Gori A, Clerici M, Sironi M (2019) Phylogenies in ART: HIV reservoirs, HIV latency and drug resistance. Curr Opin Pharmacol 48:24\u201332","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"5931_CR11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2222\/jsv.54.59","volume":"54","author":"M Baba","year":"2004","unstructured":"Baba M (2004) [Recent progress in anti-HIM-1 research]. Uirusu 54(1):59\u201366","journal-title":"Uirusu"},{"issue":"7408","key":"5931_CR12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/487439a","volume":"487","author":"SG Deeks","year":"2012","unstructured":"Deeks SG (2012) Shock and kill. Nature 487(7408):439\u2013440","journal-title":"Nature"},{"issue":"8","key":"5931_CR13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1089\/aid.2021.0195","volume":"38","author":"AT Boateng","year":"2022","unstructured":"Boateng AT, Abaidoo-Myles A, Bonney EY, Kyei GB (2022) Isoform-Selective Versus Nonselective Histone Deacetylase Inhibitors in HIV Latency Reversal. AIDS Res Hum Retroviruses 38(8):615\u2013621","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"16","key":"5931_CR14","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.2174\/138161206777442092","volume":"12","author":"RA Varier","year":"2006","unstructured":"Varier RA, Kundu TK (2006) Chromatin modifications (acetylation\/ deacetylation\/ methylation) as new targets for HIV therapy. Curr Pharm Design 12(16):1975\u20131993","journal-title":"Curr Pharm Design"},{"issue":"8","key":"5931_CR15","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1172\/JCI92684","volume":"127","author":"NM Archin","year":"2017","unstructured":"Archin NM, Kirchherr JL, Sung JA, Clutton G, Sholtis K, Xu Y, Allard B, Stuelke E, Kashuba AD, Kuruc JD, Eron J, Gay CL, Goonetilleke N, Margolis DM (2017) Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency. J Clin Investig 127(8):3126\u20133135","journal-title":"J Clin Investig"},{"issue":"37","key":"5931_CR16","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.1038\/sj.onc.1210610","volume":"26","author":"MA Glozak","year":"2007","unstructured":"Glozak MA, Seto E (2007) Histone deacetylases and cancer. Oncogene 26(37):5420\u20135432","journal-title":"Oncogene"},{"issue":"11","key":"5931_CR17","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/j.bcp.2007.02.011","volume":"73","author":"C Vandergeeten","year":"2007","unstructured":"Vandergeeten C, Quivy V, Moutschen M, Van Lint C, Piette J, Legrand-Poels S (2007) HIV-1 protease inhibitors do not interfere with provirus transcription and host cell apoptosis induced by combined treatment TNF-alpha + TSA. Biochem Pharmacol 73(11):1738\u20131748","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"5931_CR18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2174\/157016211796320333","volume":"9","author":"S Lin","year":"2011","unstructured":"Lin S, Zhang Y, Ying H, Zhu H (2011) HIV-1 reactivation induced by apicidin involves histone modification in latently infected cells. Curr HIV Res 9(4):202\u2013208","journal-title":"Curr HIV Res"},{"issue":"5","key":"5931_CR19","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/2472555220983810","volume":"26","author":"W Newhard","year":"2021","unstructured":"Newhard W, Patel M, Cassaday J, Ballard J, Squadroni B, Wu G, Liu J, Yu W, Kozlowski J, Zuck P, Howell B, Hazuda D, Vargo R, Barnard R (2021) In Vitro Pharmacokinetic\/Pharmacodynamic Modeling of HIV Latency Reversal by Novel HDAC Inhibitors Using an Automated Platform. SLAS discovery: advancing life sciences R & D 26(5):642\u2013654","journal-title":"SLAS discovery: advancing life sciences R & D"},{"issue":"4","key":"5931_CR20","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/QAD.0000000000002112","volume":"33","author":"C Garrido","year":"2019","unstructured":"Garrido C, Tolstrup M, S\u00f8gaard OS, Rasmussen TA, Allard B, Soriano-Sarabia N, Archin NM, Margolis DM (2019) In-vivo administration of histone deacetylase inhibitors does not impair natural killer cell function in HIV + individuals. AIDS 33(4):605\u2013613","journal-title":"AIDS"},{"issue":"42","key":"5931_CR21","doi-asserted-by":"crossref","first-page":"43604","DOI":"10.1074\/jbc.M408069200","volume":"279","author":"HL Kiefer","year":"2004","unstructured":"Kiefer HL, Hanley TM, Marcello JE, Karthik AG, Viglianti GA (2004) Retinoic acid inhibition of chromatin remodeling at the human immunodeficiency virus type 1 promoter. Uncoupling of histone acetylation and chromatin remodeling. J Biol Chem 279(42):43604\u201343613","journal-title":"J Biol Chem"},{"issue":"6749","key":"5931_CR22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/43710","volume":"401","author":"MS Finnin","year":"1999","unstructured":"Finnin MS, Donigian JR, Cohen A, Richon VM, Rifkind RA, Marks PA, Breslow R, Pavletich NP (1999) Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401(6749):188\u2013193","journal-title":"Nature"},{"issue":"9","key":"5931_CR23","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1128\/MCB.22.9.2965-2973.2002","volume":"22","author":"G He","year":"2002","unstructured":"He G, Margolis DM (2002) Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat. Mol Cell Biol 22(9):2965\u20132973","journal-title":"Mol Cell Biol"},{"issue":"1","key":"5931_CR24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12967-020-02318-8","volume":"18","author":"TS Iveland","year":"2020","unstructured":"Iveland TS, Hagen L, Sharma A, Sousa MML, Sarno A, Wollen KL, Liabakk NB, Slupphaug G (2020) HDACi mediate UNG2 depletion, dysregulated genomic uracil and altered expression of oncoproteins and tumor suppressors in B- and T-cell lines. J translational Med 18(1):159","journal-title":"J translational Med"},{"issue":"3","key":"5931_CR25","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.pharmthera.2014.04.004","volume":"143","author":"P Bose","year":"2014","unstructured":"Bose P, Dai Y, Grant S (2014) Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights. Pharmacol Ther 143(3):323\u2013336","journal-title":"Pharmacol Ther"},{"issue":"4","key":"5931_CR26","first-page":"314","volume":"50","author":"MY Jeng","year":"2015","unstructured":"Jeng MY, Ali I, Ott M (2015) Manipulation of the host protein acetylation network by human immunodeficiency virus type 1. Crit Rev Biochem Mol Biol 50(4):314\u2013325","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"14","key":"5931_CR27","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1074\/jbc.RA118.005185","volume":"294","author":"N Beliakova-Bethell","year":"2019","unstructured":"Beliakova-Bethell N, Mukim A, White CH, Deshmukh S, Abewe H, Richman DD, Spina CA (2019) Histone deacetylase inhibitors induce complex host responses that contribute to differential potencies of these compounds in HIV reactivation. J Biol Chem 294(14):5576\u20135589","journal-title":"J Biol Chem"},{"issue":"4","key":"5931_CR28","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/infdis\/jiaa777","volume":"224","author":"DK McMahon","year":"2021","unstructured":"McMahon DK, Zheng L, Cyktor JC, Aga E, Macatangay BJ, Godfrey C, Para M, Mitsuyasu RT, Hesselgesser J, Dragavon J, Dobrowolski C, Karn J, Acosta EP, Gandhi RT, Mellors JW (2021) Phase 1\/2 Randomized, Placebo-Controlled Trial of Romidespin in Persons With HIV-1 on Suppressive Antiretroviral Therapy. J Infect Dis 224(4):648\u2013656","journal-title":"J Infect Dis"},{"issue":"5","key":"5931_CR29","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.3892\/mmr.2017.6290","volume":"15","author":"H Zhang","year":"2017","unstructured":"Zhang H, Li X, Zhang Q, Yang F, Chu X, Zhang D, Wang L, Gong Z (2017) Role of histone deacetylase expression levels and activity in the inflammatory responses of patients with chronic hepatitis B. Mol Med Rep 15(5):2744\u20132752","journal-title":"Mol Med Rep"},{"issue":"13","key":"5931_CR30","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1158\/1078-0432.CCR-05-2689","volume":"12","author":"MH Shah","year":"2006","unstructured":"Shah MH, Binkley P, Chan K, Xiao J, Arbogast D, Collamore M, Farra Y, Young D, Grever M (2006) Cardiotoxicity of histone deacetylase inhibitor depsipeptide in patients with metastatic neuroendocrine tumors. Clin Cancer Res 12(13):3997\u20134003","journal-title":"Clin Cancer Res"},{"key":"5931_CR31","doi-asserted-by":"crossref","unstructured":"Molife R, Fong P, Scurr M, Judson I, Kaye S, de Bono J (2007) HDAC inhibitors and cardiac safety. Clin Cancer Res 13 (3), 1068; author reply 1068-9","DOI":"10.1158\/1078-0432.CCR-06-1715"},{"issue":"13","key":"5931_CR32","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.7150\/ijbs.62339","volume":"17","author":"M Bai","year":"2021","unstructured":"Bai M, Cui M, Li M, Yao X, Wu Y, Zheng L, Sun L, Song Q, Wang S, Liu L, Yu C, Huang Y (2021) Discovery of a novel HDACi structure that inhibits the proliferation of ovarian cancer cells in vivo and in vitro. Int J Biol Sci 17(13):3493\u20133507","journal-title":"Int J Biol Sci"},{"issue":"16","key":"5931_CR33","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.18632\/oncotarget.2289","volume":"5","author":"M Kroesen","year":"2014","unstructured":"Kroesen M, Gielen P, Brok IC, Armandari I, Hoogerbrugge PM, Adema GJ (2014) HDAC inhibitors and immunotherapy; a double edged sword? Oncotarget 5(16):6558\u20136572","journal-title":"Oncotarget"},{"issue":"9","key":"5931_CR34","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.3390\/ph3092751","volume":"3","author":"S Subramanian","year":"2010","unstructured":"Subramanian S, Bates SE, Wright JJ, Espinoza-Delgado I, Piekarz RL (2010) Clinical Toxicities of Histone Deacetylase Inhibitors. Pharmaceuticals (Basel Switzerland) 3(9):2751\u20132767","journal-title":"Pharmaceuticals (Basel Switzerland)"},{"issue":"2","key":"5931_CR35","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.emboj.7601517","volume":"26","author":"I du Ch\u00e9n\u00e9","year":"2007","unstructured":"du Ch\u00e9n\u00e9 I, Basyuk E, Lin YL, Triboulet R, Knezevich A, Chable-Bessia C, Mettling C, Baillat V, Reynes J, Corbeau P, Bertrand E, Marcello A, Emiliani S, Kiernan R, Benkirane M (2007) Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency. Embo j 26(2):424\u2013435","journal-title":"Embo j"},{"issue":"2","key":"5931_CR36","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/sj.emboj.7601516","volume":"26","author":"C Marban","year":"2007","unstructured":"Marban C, Suzanne S, Dequiedt F, de Walque S, Redel L, Van Lint C, Aunis D, Rohr O (2007) Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. Embo j 26(2):412\u2013423","journal-title":"Embo j"},{"issue":"22","key":"5931_CR37","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.febslet.2011.10.018","volume":"585","author":"W Bernhard","year":"2011","unstructured":"Bernhard W, Barreto K, Saunders A, Dahabieh MS, Johnson P, Sadowski I (2011) The Suv39H1 methyltransferase inhibitor chaetocin causes induction of integrated HIV-1 without producing a T cell response. FEBS Lett 585(22):3549\u20133554","journal-title":"FEBS Lett"},{"issue":"12","key":"5931_CR38","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/QAD.0b013e32835535f5","volume":"26","author":"S Bouchat","year":"2012","unstructured":"Bouchat S, Gatot JS, Kabeya K, Cardona C, Colin L, Herbein G, De Wit S, Clumeck N, Lambotte O, Rouzioux C, Rohr O, Van Lint C (2012) Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4(+) T cells from HIV-1-infected HAART-treated patients. AIDS 26(12):1473\u20131482","journal-title":"AIDS"},{"key":"5931_CR39","unstructured":"Rombo R, Weiher H, Schmidt-Wolf IG (2016) Effect of chaetocin on renal cell carcinoma cells and cytokine-induced killer cells. German medical science: GMS e-journal 14, Doc04"},{"issue":"22","key":"5931_CR40","doi-asserted-by":"crossref","first-page":"16538","DOI":"10.1074\/jbc.M110.103531","volume":"285","author":"K Imai","year":"2010","unstructured":"Imai K, Togami H, Okamoto T (2010) Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294. J Biol Chem 285(22):16538\u201316545","journal-title":"J Biol Chem"},{"key":"5931_CR41","doi-asserted-by":"crossref","unstructured":"Chase KA, Feiner B, Ramaker MJ, Hu E, Rosen C, Sharma RP (2019) Examining the effects of the histone methyltransferase inhibitor BIX-01294 on histone modifications and gene expression in both a clinical population and mouse models. PLoS ONE 14 (6), e0216463","DOI":"10.1371\/journal.pone.0216463"},{"issue":"10","key":"5931_CR42","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1080\/15592294.2016.1221569","volume":"11","author":"X Zhang","year":"2016","unstructured":"Zhang X, Justice AC, Hu Y, Wang Z, Zhao H, Wang G, Johnson EO, Emu B, Sutton RE, Krystal JH, Xu K (2016) Epigenome-wide differential DNA methylation between HIV-infected and uninfected individuals. Epigenetics 11(10):750\u2013760","journal-title":"Epigenetics"},{"issue":"8","key":"5931_CR43","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/15592294.2015.1062204","volume":"10","author":"MG van der Wijst","year":"2015","unstructured":"van der Wijst MG, Venkiteswaran M, Chen H, Xu GL, Pl\u00f6sch T, Rots MG (2015) Local chromatin microenvironment determines DNMT activity: from DNA methyltransferase to DNA demethylase or DNA dehydroxymethylase. Epigenetics 10(8):671\u2013676","journal-title":"Epigenetics"},{"issue":"25","key":"5931_CR44","doi-asserted-by":"crossref","first-page":"19434","DOI":"10.1074\/jbc.M110.107607","volume":"285","author":"V Pierard","year":"2010","unstructured":"Pierard V, Guiguen A, Colin L, Wijmeersch G, Vanhulle C, Van Driessche B, Dekoninck A, Blazkova J, Cardona C, Merimi M, Vierendeel V, Calomme C, Nguy\u00ean TL, Nuttinck M, Twizere JC, Kettmann R, Portetelle D, Burny A, Hirsch I, Rohr O, Van Lint C (2010) DNA cytosine methylation in the bovine leukemia virus promoter is associated with latency in a lymphoma-derived B-cell line: potential involvement of direct inhibition of cAMP-responsive element (CRE)-binding protein\/CRE modulator\/activation transcription factor binding. J Biol Chem 285(25):19434\u201319449","journal-title":"J Biol Chem"},{"issue":"2","key":"5931_CR45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.15252\/emmm.201505557","volume":"8","author":"S Bouchat","year":"2016","unstructured":"Bouchat S, Delacourt N, Kula A, Darcis G, Van Driessche B, Corazza F, Gatot JS, Melard A, Vanhulle C, Kabeya K, Pardons M, Avettand-Fenoel V, Clumeck N, De Wit S, Rohr O, Rouzioux C, Van Lint C (2016) Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1. EMBO Mol Med 8(2):117\u2013138","journal-title":"EMBO Mol Med"},{"key":"5931_CR46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-3-319-24738-0_2","volume":"879","author":"EA Abdel-Hameed","year":"2016","unstructured":"Abdel-Hameed EA, Ji H, Shata MT (2016) HIV-Induced Epigenetic Alterations in Host Cells. Adv Exp Med Biol 879:27\u201338","journal-title":"Adv Exp Med Biol"},{"issue":"21","key":"5931_CR47","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1182\/bloodadvances.2020002544","volume":"4","author":"B Oran","year":"2020","unstructured":"Oran B, de Lima M, Garcia-Manero G, Thall PF, Lin R, Popat U, Alousi AM, Hosing C, Giralt S, Rondon G, Woodworth G, Champlin RE (2020) A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients. Blood Adv 4(21):5580\u20135588","journal-title":"Blood Adv"},{"key":"5931_CR48","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/1743-422X-7-266","volume":"7","author":"G Fernandez","year":"2010","unstructured":"Fernandez G, Zeichner SL (2010) Cell line-dependent variability in HIV activation employing DNMT inhibitors. Virol J 7:266","journal-title":"Virol J"},{"issue":"5","key":"5931_CR49","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/annonc\/mdg216","volume":"14","author":"DJ Stewart","year":"2003","unstructured":"Stewart DJ, Donehower RC, Eisenhauer EA, Wainman N, Shah AK, Bonfils C, MacLeod AR, Besterman JM, Reid GK (2003) A phase I pharmacokinetic and pharmacodynamic study of the DNA methyltransferase 1 inhibitor MG98 administered twice weekly. Annals of oncology: official journal of the European Society for Medical Oncology 14(5):766\u2013774","journal-title":"Annals of oncology: official journal of the European Society for Medical Oncology"},{"issue":"2","key":"5931_CR50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10637-006-5938-1","volume":"24","author":"E Winquist","year":"2006","unstructured":"Winquist E, Knox J, Ayoub JP, Wood L, Wainman N, Reid GK, Pearce L, Shah A, Eisenhauer E (2006) Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: a National Cancer Institute of Canada Clinical Trials Group investigational new drug study. Invest New Drugs 24(2):159\u2013167","journal-title":"Invest New Drugs"},{"issue":"9","key":"5931_CR51","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1158\/1078-0432.CCR-08-2859","volume":"15","author":"R Plummer","year":"2009","unstructured":"Plummer R, Vidal L, Griffin M, Lesley M, de Bono J, Coulthard S, Sludden J, Siu LL, Chen EX, Oza AM, Reid GK, McLeod AR, Besterman JM, Lee C, Judson I, Calvert H, Boddy AV (2009) Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors. Clin Cancer Res 15(9):3177\u20133183","journal-title":"Clin Cancer Res"},{"issue":"Suppl 1","key":"5931_CR52","first-page":"S75","volume":"38","author":"J Zaborowska","year":"2016","unstructured":"Zaborowska J, Isa NF, Murphy S (2016) P-TEFb goes viral. BioEssays 38(Suppl 1):S75\u201385","journal-title":"BioEssays"},{"issue":"2","key":"5931_CR53","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/jcb.26293","volume":"119","author":"LC Franco","year":"2018","unstructured":"Franco LC, Morales F, Boffo S, Giordano A (2018) CDK9: A key player in cancer and other diseases. J Cell Biochem 119(2):1273\u20131284","journal-title":"J Cell Biochem"},{"key":"5931_CR54","doi-asserted-by":"crossref","unstructured":"Chen D, Wang H, Aweya JJ, Chen Y, Chen M, Wu X, Chen X, Lu J, Chen R, Liu M (2016) HMBA Enhances Prostratin-Induced Activation of Latent HIV-1 via Suppressing the Expression of Negative Feedback Regulator A20\/TNFAIP3 in NF-\u03baB Signaling. Biomed Res Int 2016. 5173205","DOI":"10.1155\/2016\/5173205"},{"issue":"10","key":"5931_CR55","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1371\/journal.ppat.0030146","volume":"3","author":"X Contreras","year":"2007","unstructured":"Contreras X, Barboric M, Lenasi T, Peterlin BM (2007) HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K\/Akt and activates HIV transcription. PLoS Pathog 3(10):1459\u20131469","journal-title":"PLoS Pathog"},{"issue":"7","key":"5931_CR56","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/labinvest.2012.59","volume":"92","author":"Y Cheng","year":"2012","unstructured":"Cheng Y, Jin Z, Agarwal R, Ma K, Yang J, Ibrahim S, Olaru AV, David S, Ashktorab H, Smoot DT, Duncan MD, Hutcheon DF, Abraham JM, Meltzer SJ, Mori Y (2012) LARP7 is a potential tumor suppressor gene in gastric cancer. Lab Invest 92(7):1013\u20131019","journal-title":"Lab Invest"},{"issue":"15","key":"5931_CR57","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.4161\/cc.6.15.4556","volume":"6","author":"A Dey","year":"2007","unstructured":"Dey A, Chao SH, Lane DP (2007) HEXIM1 and the control of transcription elongation: from cancer and inflammation to AIDS and cardiac hypertrophy. Cell Cycle 6(15):1856\u20131863","journal-title":"Cell Cycle"},{"issue":"3","key":"5931_CR58","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/jcp.20698","volume":"208","author":"PP Claudio","year":"2006","unstructured":"Claudio PP, Cui J, Ghafouri M, Mariano C, White MK, Safak M, Sheffield JB, Giordano A, Khalili K, Amini S, Sawaya BE (2006) Cdk9 phosphorylates p53 on serine 392 independently of CKII. J Cell Physiol 208(3):602\u2013612","journal-title":"J Cell Physiol"},{"issue":"26","key":"5931_CR59","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1038\/sj.onc.1205511","volume":"21","author":"C Simone","year":"2002","unstructured":"Simone C, Bagella L, Bellan C, Giordano A (2002) Physical interaction between pRb and cdk9\/cyclinT2 complex. Oncogene 21(26):4158\u20134165","journal-title":"Oncogene"},{"key":"5931_CR60","doi-asserted-by":"crossref","unstructured":"Fujinaga K (2020) P-TEFb as A Promising Therapeutic Target. Molecules 25 (4)","DOI":"10.3390\/molecules25040838"},{"issue":"1","key":"5931_CR61","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1038\/s41598-018-21942-5","volume":"8","author":"J Gohda","year":"2018","unstructured":"Gohda J, Suzuki K, Liu K, Xie X, Takeuchi H, Inoue JI, Kawaguchi Y, Ishida T (2018) BI-2536 and BI-6727, dual Polo-like kinase\/bromodomain inhibitors, effectively reactivate latent HIV-1. Sci Rep 8(1):3521","journal-title":"Sci Rep"},{"issue":"7","key":"5931_CR62","doi-asserted-by":"crossref","first-page":"e1005063","DOI":"10.1371\/journal.ppat.1005063","volume":"11","author":"G Darcis","year":"2015","unstructured":"Darcis G, Kula A, Bouchat S, Fujinaga K, Corazza F, Ait-Ammar A, Delacourt N, Melard A, Kabeya K, Vanhulle C, Van Driessche B, Gatot JS, Cherrier T, Pianowski LF, Gama L, Schwartz C, Vila J, Burny A, Clumeck N, Moutschen M, De Wit S, Peterlin BM, Rouzioux C, Rohr O, Van Lint C (2015) An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1 + JQ1 and Ingenol-B + JQ1 to Potently Reactivate Viral Gene Expression. PLoS Pathog 11(7):e1005063","journal-title":"PLoS Pathog"},{"issue":"1","key":"5931_CR63","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12974-019-1511-7","volume":"16","author":"J S\u00e1nchez-Ventura","year":"2019","unstructured":"S\u00e1nchez-Ventura J, Amo-Aparicio J, Navarro X, Penas C (2019) BET protein inhibition regulates cytokine production and promotes neuroprotection after spinal cord injury. J Neuroinflamm 16(1):124","journal-title":"J Neuroinflamm"},{"issue":"11","key":"5931_CR64","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/eji.201848081","volume":"49","author":"J Dom\u00ednguez-Andr\u00e9s","year":"2019","unstructured":"Dom\u00ednguez-Andr\u00e9s J, Ferreira AV, Jansen T, Smithers N, Prinjha RK, Furze RC, Netea MG (2019) Bromodomain inhibitor I-BET151 suppresses immune responses during fungal-immune interaction. Eur J Immunol 49(11):2044\u20132050","journal-title":"Eur J Immunol"},{"key":"5931_CR65","doi-asserted-by":"crossref","unstructured":"Salahong T, Schwartz C, Sungthong R, Are BET (2021) Inhibitors yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy? Viruses 13 (6)","DOI":"10.3390\/v13061026"},{"issue":"1","key":"5931_CR66","doi-asserted-by":"crossref","first-page":"16646","DOI":"10.1038\/s41598-017-16816-1","volume":"7","author":"P Lu","year":"2017","unstructured":"Lu P, Shen Y, Yang H, Wang Y, Jiang Z, Yang X, Zhong Y, Pan H, Xu J, Lu H, Zhu H (2017) BET inhibitors RVX-208 and PFI-1 reactivate HIV-1 from latency. Sci Rep 7(1):16646","journal-title":"Sci Rep"},{"key":"5931_CR67","first-page":"12","volume":"93","author":"G Li","year":"2019","unstructured":"Li G, Zhang Z, Reszka-Blanco N, Li F, Chi L, Ma J, Jeffrey J, Cheng L, Su L (2019) Specific Activation in Vivo of HIV-1 by a Bromodomain Inhibitor from Monocytic Cells in Humanized Mice under Antiretroviral Therapy. J Virol 93:12","journal-title":"J Virol"},{"issue":"2","key":"5931_CR68","doi-asserted-by":"crossref","first-page":"F7","DOI":"10.1097\/QAD.0b013e3283570620","volume":"27","author":"G Doyon","year":"2013","unstructured":"Doyon G, Zerbato J, Mellors JW, Sluis-Cremer N (2013) Disulfiram reactivates latent HIV-1 expression through depletion of the phosphatase and tensin homolog. AIDS 27(2):F7\u2013f11","journal-title":"AIDS"},{"issue":"12","key":"5931_CR69","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1128\/JVI.02033-10","volume":"85","author":"S Xing","year":"2011","unstructured":"Xing S, Bullen CK, Shroff NS, Shan L, Yang HC, Manucci JL, Bhat S, Zhang H, Margolick JB, Quinn TC, Margolis DM, Siliciano JD, Siliciano RF (2011) Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4 + T cell model without inducing global T cell activation. J Virol 85(12):6060\u20136064","journal-title":"J Virol"},{"key":"5931_CR70","doi-asserted-by":"crossref","unstructured":"Spivak AM, Andrade A, Eisele E, Hoh R, Bacchetti P, Bumpus NN, Emad F, Buckheit R 3rd;, McCance-Katz EF, Lai J, Kennedy M, Chander G, Siliciano RF, Siliciano JD, Deeks SG (2014) A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy. Clin Infect diseases: official publication Infect Dis Soc Am 58(6):883\u2013890","DOI":"10.1093\/cid\/cit813"},{"issue":"3","key":"5931_CR71","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/cpt.1220","volume":"105","author":"SA Lee","year":"2019","unstructured":"Lee SA, Elliott JH, McMahon J, Hartogenesis W, Bumpus NN, Lifson JD, Gorelick RJ, Bacchetti P, Deeks SG, Lewin SR, Savic RM (2019) Population Pharmacokinetics and Pharmacodynamics of Disulfiram on Inducing Latent HIV-1 Transcription in a Phase IIb Trial. Clin Pharmacol Ther 105(3):692\u2013702","journal-title":"Clin Pharmacol Ther"},{"key":"5931_CR72","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/v10080409","volume":"10","author":"L Deng","year":"2018","unstructured":"Deng L, Zeng Q, Wang M, Cheng A, Jia R, Chen S, Zhu D, Liu M, Yang Q, Wu Y, Zhao X, Zhang S, Liu Y, Yu Y, Zhang L, Chen X (2018) Suppression of NF-\u03baB Activity: A Viral Immune Evasion Mechanism. Viruses 10:8","journal-title":"Viruses"},{"key":"5931_CR73","doi-asserted-by":"crossref","unstructured":"Khan SZ, Gasperino S, Zeichner SL (2019) Nuclear Transit and HIV LTR Binding of NF-\u03baB Subunits Held by I\u03baB Proteins: Implications for HIV-1 Activation. Viruses 11 (12)","DOI":"10.3390\/v11121162"},{"issue":"7","key":"5931_CR74","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1128\/JVI.03251-12","volume":"87","author":"G Fernandez","year":"2013","unstructured":"Fernandez G, Zaikos TD, Khan SZ, Jacobi AM, Behlke MA, Zeichner SL (2013) Targeting I\u03baB proteins for HIV latency activation: the role of individual I\u03baB and NF-\u03baB proteins. J Virol 87(7):3966\u20133978","journal-title":"J Virol"},{"key":"5931_CR75","doi-asserted-by":"crossref","unstructured":"Mbonye U, Leskov K, Shukla M, Valadkhan S, Karn J (2021) Biogenesis of P-TEFb in CD4 + T cells to reverse HIV latency is mediated by protein kinase C (PKC)-independent signaling pathways. PLoS Pathog 17 (9), e1009581","DOI":"10.1371\/journal.ppat.1009581"},{"key":"5931_CR76","doi-asserted-by":"crossref","unstructured":"Okoye AA, Fromentin R, Takata H, Brehm JH, Fukazawa Y, Randall B, Pardons M, Tai V, Tang J, Smedley J, Axthelm M, Lifson JD, Picker LJ, Favre D, Trautmann L, Chomont N (2022) The ingenol-based protein kinase C agonist GSK445A is a potent inducer of HIV and SIV RNA transcription. PLoS Pathog 18 (1), e1010245","DOI":"10.1371\/journal.ppat.1010245"},{"issue":"9","key":"5931_CR77","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/QAD.0000000000001064","volume":"30","author":"C Guti\u00e9rrez","year":"2016","unstructured":"Guti\u00e9rrez C, Serrano-Villar S, Madrid-Elena N, P\u00e9rez-El\u00edas MJ, Mart\u00edn ME, Barbas C, Ruip\u00e9rez J, Mu\u00f1oz E, Mu\u00f1oz-Fern\u00e1ndez MA, Castor T, Moreno S (2016) Bryostatin-1 for latent virus reactivation in HIV-infected patients on antiretroviral therapy. AIDS 30(9):1385\u20131392","journal-title":"AIDS"},{"issue":"1","key":"5931_CR78","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/QAD.0000000000001267","volume":"31","author":"L Gama","year":"2017","unstructured":"Gama L, Abreu CM, Shirk EN, Price SL, Li M, Laird GM, Pate KA, Wietgrefe SW, O'Connor SL, Pianowski L, Haase AT, Van Lint C, Siliciano RF, Clements JE (2017) Reactivation of simian immunodeficiency virus reservoirs in the brain of virally suppressed macaques. AIDS 31(1):5\u201314","journal-title":"AIDS"},{"key":"5931_CR79","doi-asserted-by":"crossref","unstructured":"Marsden MD, Loy BA, Wu X, Ramirez CM, Schrier AJ, Murray D, Shimizu A, Ryckbosch SM, Near KE, Chun TW, Wender PA, Zack JA (2017) In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell kick and kill in strategy for virus eradication. PLoS Pathog 13 (9), e1006575","DOI":"10.1371\/journal.ppat.1006575"},{"issue":"29","key":"5931_CR80","doi-asserted-by":"crossref","first-page":"11698","DOI":"10.1073\/pnas.1302634110","volume":"110","author":"EJ Beans","year":"2013","unstructured":"Beans EJ, Fournogerakis D, Gauntlett C, Heumann LV, Kramer R, Marsden MD, Murray D, Chun TW, Zack JA, Wender PA (2013) Highly potent, synthetically accessible prostratin analogs induce latent HIV expression in vitro and ex vivo. Proc Natl Acad Sci USA 110(29):11698\u201311703","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"5931_CR81","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nchem.1395","volume":"4","author":"BA DeChristopher","year":"2012","unstructured":"DeChristopher BA, Loy BA, Marsden MD, Schrier AJ, Zack JA, Wender PA (2012) Designed, synthetically accessible bryostatin analogues potently induce activation of latent HIV reservoirs in vitro. Nat Chem 4(9):705\u2013710","journal-title":"Nat Chem"},{"key":"5931_CR82","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1749-6632.2000.tb05462.x","volume":"917","author":"M Clerici","year":"2000","unstructured":"Clerici M, Galli M, Bosis S, Gervasoni C, Moroni M, Norbiato G (2000) Immunoendocrinologic abnormalities in human immunodeficiency virus infection. Ann N Y Acad Sci 917:956\u2013961","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"5931_CR83","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.it.2004.05.007","volume":"25","author":"H Nakano","year":"2004","unstructured":"Nakano H (2004) Signaling crosstalk between NF-kappaB and JNK. Trends Immunol 25(8):402\u2013405","journal-title":"Trends Immunol"},{"issue":"6","key":"5931_CR84","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1159\/000350517","volume":"5","author":"KA Khan","year":"2013","unstructured":"Khan KA, Abbas W, Varin A, Kumar A, Di Martino V, Dichamp I, Herbein G (2013) HIV-1 Nef interacts with HCV Core, recruits TRAF2, TRAF5 and TRAF6, and stimulates HIV-1 replication in macrophages. J Innate Immun 5(6):639\u2013656","journal-title":"J Innate Immun"},{"key":"5931_CR85","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ebiom.2016.11.009","volume":"13","author":"G Herbein","year":"2016","unstructured":"Herbein G (2016) HIV-1 Nef: An Intimate Interplay. EBioMedicine 13:25\u201326","journal-title":"EBioMedicine"},{"key":"5931_CR86","doi-asserted-by":"crossref","unstructured":"Reuse S, Calao M, Kabeya K, Guiguen A, Gatot JS, Quivy V, Vanhulle C, Lamine A, Vaira D, Demonte D, Martinelli V, Veithen E, Cherrier T, Avettand V, Poutrel S, Piette J, de Launoit Y, Moutschen M, Burny A, Rouzioux C, De Wit S, Herbein G, Rohr O, Collette Y, Lambotte O, Clumeck N, Van Lint C (2009) Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PLoS ONE 4 (6), e6093","DOI":"10.1371\/journal.pone.0006093"},{"issue":"11","key":"5931_CR87","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1038\/cddis.2010.77","volume":"1","author":"NW Cummins","year":"2010","unstructured":"Cummins NW, Badley AD (2010) Mechanisms of HIV-associated lymphocyte apoptosis: 2010. Cell Death Dis 1(11):e99","journal-title":"Cell Death Dis"},{"issue":"2","key":"5931_CR88","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cpt.2237","volume":"110","author":"CV Fletcher","year":"2021","unstructured":"Fletcher CV, Dyavar SR, Acharya A, Byrareddy SN (2021) The Contributions of Clinical Pharmacology to HIV Cure Research. Clin Pharmacol Ther 110(2):334\u2013345","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"5931_CR89","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.chom.2017.12.004","volume":"23","author":"Y Kim","year":"2018","unstructured":"Kim Y, Anderson JL, Lewin SR (2018) Getting the Kill into Shock and Kill: Strategies to Eliminate Latent HIV. Cell Host Microbe 23(1):14\u201326","journal-title":"Cell Host Microbe"},{"key":"5931_CR90","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.antiviral.2019.05.003","volume":"168","author":"E Garcia-Vidal","year":"2019","unstructured":"Garcia-Vidal E, Badia R, Pujantell M, Castellv\u00ed M, Felip E, Clotet B, Riveira-Mu\u00f1oz E, Ballana E, Est\u00e9 JA (2019) Dual effect of the broad spectrum kinase inhibitor midostaurin in acute and latent HIV-1 infection. Antiviral Res 168:18\u201327","journal-title":"Antiviral Res"},{"issue":"2","key":"5931_CR91","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1172\/JCI80565","volume":"126","author":"DC Cary","year":"2016","unstructured":"Cary DC, Fujinaga K, Peterlin BM (2016) Molecular mechanisms of HIV latency. J Clin Investig 126(2):448\u2013454","journal-title":"J Clin Investig"},{"issue":"9\u201310","key":"5931_CR92","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.micinf.2017.10.003","volume":"20","author":"W Yang","year":"2018","unstructured":"Yang W, Sun Z, Hua C, Wang Q, Xu W, Deng Q, Pan Y, Lu L, Jiang S (2018) Chidamide, a histone deacetylase inhibitor-based anticancer drug, effectively reactivates latent HIV-1 provirus. Microbes Infect 20(9\u201310):626\u2013634","journal-title":"Microbes Infect"},{"issue":"9","key":"5931_CR93","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jmv.25207","volume":"90","author":"Q Kuai","year":"2018","unstructured":"Kuai Q, Lu X, Qiao Z, Wang R, Wang Y, Ye S, He M, Wang Y, Zhang T, Wu H, Ren S, Yu Q (2018) Histone deacetylase inhibitor chidamide promotes reactivation of latent human immunodeficiency virus by introducing histone acetylation. J Med Virol 90(9):1478\u20131485","journal-title":"J Med Virol"},{"issue":"11","key":"5931_CR94","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/hiv.13027","volume":"21","author":"JH Li","year":"2020","unstructured":"Li JH, Ma J, Kang W, Wang CF, Bai F, Zhao K, Yao N, Liu Q, Dang BL, Wang BW, Wei QQ, Kang WZ, Sun YT (2020) The histone deacetylase inhibitor chidamide induces intermittent viraemia in HIV-infected patients on suppressive antiretroviral therapy. HIV Med 21(11):747\u2013757","journal-title":"HIV Med"}],"updated-by":[{"DOI":"10.1007\/s00705-024-05972-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000}}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-023-05931-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-023-05931-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-023-05931-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T16:11:52Z","timestamp":1708359112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-023-05931-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":94,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["5931"],"URL":"https:\/\/doi.org\/10.1007\/s00705-023-05931-2","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]},"assertion":[{"value":"2 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00705-024-05972-1","URL":"https:\/\/doi.org\/10.1007\/s00705-024-05972-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"301"}}